SKYSTAR BIO-PHARMACEUTICAL CO Comprehensive Income
SKYSTAR BIO-PHARMACEUTICAL CO reported Comprehensive Income of $4.90 million for the 3-month period ending 2014-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2014-09-30 was $4.90M, a 15.47% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2014-06-30 was $2.95M, a 44.03% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2014-03-31 was $8.50K, a 99.33% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2013-12-31 was $2.79M, a 4898.42% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for fiscal 2013 was $13.57M, a 97.35% increase from fiscal 2012.
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for fiscal 2012 was $6.87M, a 58.62% decline from fiscal 2011.
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for fiscal 2011 was $16.61M, a 1.47% increase from fiscal 2010.
- SKYSTAR BIO-PHARMACEUTICAL CO comprehensive income (loss), net of tax, attributable to parent for fiscal 2010 was $16.37M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2014-09-30 | $4.90M 10-Q · filed 2014-11-14 | $7.85M derived: sum of 2 quarters · filed 2014-11-14 | $7.86M 10-Q · filed 2014-11-14 | $10.65M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-06-30 | $2.95M 10-Q · filed 2014-08-14 | $2.95M 10-Q · filed 2014-08-14 | $5.75M derived: sum of 3 quarters · filed 2014-08-14 | $10.00M derived: sum of 4 quarters · filed 2014-11-14 |
| 2014-03-31 | $8.50K 10-Q · filed 2014-05-15 | $2.80M derived: sum of 2 quarters · filed 2014-05-15 | $7.05M derived: sum of 3 quarters · filed 2014-11-14 | $12.31M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $7.04M derived: sum of 2 quarters · filed 2014-11-14 | $12.30M derived: sum of 3 quarters · filed 2014-11-14 | $13.57M 10-K · filed 2014-03-31 |
| 2013-09-30 | $4.25M 10-Q · filed 2014-11-14 | $9.51M derived: sum of 2 quarters · filed 2014-11-14 | $10.77M 10-Q · filed 2014-11-14 | $10.83M derived: sum of 4 quarters · filed 2014-11-14 |
| 2013-06-30 | $5.26M 10-Q · filed 2014-08-14 | $6.53M 10-Q · filed 2014-08-14 | $6.58M derived: sum of 3 quarters · filed 2014-08-14 | $9.12M derived: sum of 4 quarters · filed 2014-08-14 |
| 2013-03-31 | $1.26M 10-Q · filed 2014-05-15 | $1.32M derived: sum of 2 quarters · filed 2014-05-15 | $3.85M derived: sum of 3 quarters · filed 2014-05-15 | $5.68M derived: sum of 4 quarters · filed 2014-05-15 |
| 2012-12-31 | $55.89K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $2.59M derived: sum of 2 quarters · filed 2014-03-31 | $4.41M derived: sum of 3 quarters · filed 2014-03-31 | $6.87M 10-K · filed 2014-03-31 |
| 2012-09-30 | $2.53M 10-Q · filed 2013-11-14 | $4.36M derived: sum of 2 quarters · filed 2013-11-14 | $6.82M 10-Q · filed 2013-11-14 | $9.77M derived: sum of 4 quarters · filed 2013-11-14 |
| 2012-06-30 | $1.82M 10-Q · filed 2013-08-14 | $4.29M 10-Q · filed 2013-08-14 | $7.24M derived: sum of 3 quarters · filed 2013-08-14 | $15.86M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $2.46M 10-Q · filed 2013-05-15 | $5.41M derived: sum of 2 quarters · filed 2013-05-15 | $14.04M derived: sum of 3 quarters · filed 2013-05-15 | $16.68M derived: sum of 4 quarters · filed 2013-05-15 |
| 2011-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $11.58M derived: sum of 2 quarters · filed 2013-04-01 | $14.22M derived: sum of 3 quarters · filed 2013-04-01 | $16.61M 10-K · filed 2013-04-01 |
| 2011-09-30 | $8.63M 10-Q · filed 2012-11-14 | $11.26M derived: sum of 2 quarters · filed 2012-11-14 | $13.66M 10-Q · filed 2012-11-14 | $18.66M derived: sum of 4 quarters · filed 2012-11-14 |
| 2011-06-30 | $2.64M 10-Q/A · filed 2012-09-13 | $5.04M 10-Q/A · filed 2012-09-13 | $10.03M derived: sum of 3 quarters · filed 2012-09-13 | $17.69M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | $2.40M 10-Q · filed 2012-05-15 | $7.39M derived: sum of 2 quarters · filed 2012-05-15 | $15.06M derived: sum of 3 quarters · filed 2012-05-15 | $17.71M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $12.66M derived: sum of 2 quarters · filed 2012-03-30 | $15.32M derived: sum of 3 quarters · filed 2012-03-30 | $16.37M 10-K · filed 2012-03-30 |
| 2010-09-30 | $7.66M 10-Q · filed 2011-11-14 | $10.32M derived: sum of 2 quarters · filed 2011-11-14 | $11.38M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $2.66M 10-Q/A · filed 2011-09-21 | $3.71M 10-Q/A · filed 2011-09-21 |